Clinical Trials

Showing trials with last updates posted in 2026.

NCT07365306 | RECRUITING | PHASE2
43 participants

Epcoritamab, Rituximab, Gemcitabine and Oxaliplatin (R-GemOx) as Salvage Therapy Before Autologous Stem Cell Transplant for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-28
Start Date:
2026-07-27
Completion:
2029-10-15
Conditions
  • Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
  • Recurrent High Grade B-Cell Lymphoma, Not Otherwise Specified
  • Recurrent Primary Mediastinal Large B-Cell Lymphoma
  • Recurrent Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma
  • Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
  • Refractory High Grade B-Cell Lymphoma, Not Otherwise Specified
  • Refractory Primary Mediastinal Large B-Cell Lymphoma
  • Refractory Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma
Interventions
  • PROCEDURE
  • BIOLOGICAL
  • DRUG
No Results Yet
NCT07340047 | WITHDRAWN | PHASE1
0 participants

H1ssF Flu Vaccine Clinical Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-28
Start Date:
2026-08-01
Completion:
2028-03-01
Conditions
  • Influenza
Interventions
  • BIOLOGICAL
No Results Yet
NCT07293689 | RECRUITING
200 participants

PREcision MEDicine In Achalasia (PREMEDIA) - Cohort

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-28
Start Date:
2026-12-01
Completion:
2031-08-31
Conditions
  • Type III Achalasia
  • EGJ Outflow Obstruction With Spastic/Hypercontractile Features
  • Jackhammer Esophagus
  • Distal Esophageal Spasm
No Results Yet
NCT07293650 | RECRUITING | PHASE3
372 participants

PREcision MEDicine In Achalasia (PREMEDIA)

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-28
Start Date:
2026-04-29
Completion:
2031-08-31
Conditions
  • Type I Achalasia
  • Type II Achalasia
  • EGJ Outflow Obstruction Without Spastic/Hypercontractile Features
Interventions
  • PROCEDURE
No Results Yet
NCT07281417 | RECRUITING | PHASE2
108 participants

Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell Carcinoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-28
Start Date:
2026-11-24
Completion:
2030-12-16
Conditions
  • Sinonasal Squamous Cell Carcinoma
  • Stage III Sinonasal Cancer AJCC v8
  • Stage IVA Sinonasal Cancer AJCC v8
  • Stage IVB Sinonasal Cancer AJCC v8
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
  • OTHER
  • RADIATION
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page